Zobrazeno 1 - 10
of 8 552
pro vyhledávání: '"psychiatric comorbidity"'
Publikováno v:
Annals of Indian Psychiatry, Vol 8, Iss 4, Pp 285-291 (2024)
Introduction: Alcohol dependence syndrome (ADS) is a significant health problem all over the world. Alcohol-dependent individuals have a high prevalence of psychiatric comorbidities and nonadaptive personality traits that may influence the pathogenes
Externí odkaz:
https://doaj.org/article/ece7927d4b9e433ab90c6c3acfc128fb
Autor:
Piotr Engelgardt, Maciej Krzyżanowski, Małgorzata Borkowska-Sztachańska, Agnieszka Wasilewska, Michał Ciucias
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract It is well-recognized that individuals with alcohol-related disorders often use other psychoactive substances; however, systematic research on this topic remains limited. The primary objective was to determine the prevalence of lifetime psyc
Externí odkaz:
https://doaj.org/article/3e3dd4dfc1aa46dea6a8875107fd37b3
Autor:
Teresa López-Castro, Nancy Sohler, Lindsey Riback, Gina Bravo, Eric Ohlendorf, Megan Ghiroli, Aaron D. Fox
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-9 (2024)
Abstract Background Syringe services programs (SSPs) are critical healthcare access points for people with opioid use disorder (OUD) who face treatment utilization barriers. Co-locating care for common psychiatric comorbidities, like posttraumatic st
Externí odkaz:
https://doaj.org/article/bc489aeba238461da1beb3e54c83630a
Publikováno v:
Annals of Indian Academy of Neurology, Vol 27, Iss 3, Pp 254-263 (2024)
Objective: To assess attention, vigilance, and executive functions in migraine patients during headache-free (interictal) periods and in healthy controls without migraine and to study the impact of migraine preventive treatment on these cognitive fun
Externí odkaz:
https://doaj.org/article/533ea39786484c328452d7f8621b7c62
Publikováno v:
Addiction Science & Clinical Practice, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Knowledge of co-occurring mental disorders (termed ‘dual diagnosis’) among patients receiving opioid agonist treatment (OAT) is scarce. This study aimed (1) to estimate the prevalence and structure of dual diagnoses in two nat
Externí odkaz:
https://doaj.org/article/310d9b23dc4341008ae3f87572077137
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background To explore the demographic and clinical features of current depressive episode that discriminate patients diagnosed with major depressive disorder (MDD) from those with bipolar I (BP-I) and bipolar II (BP-II) disorder who were mis
Externí odkaz:
https://doaj.org/article/76876b39effc43dfa0e77e4ab967d539
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 17, Pp 411-420 (2024)
Yen-Hsun Huang,1 Hsien-Chih Chiou,1 Chun-Hung Pan,1,2 I-Shuan Wang,1 Ya-Tang Liao,3 Sheng-Siang Su,1 Chiao-Chicy Chen,4– 6 Chian-Jue Kuo1,4,5 1Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan; 2Department of Psychology, National
Externí odkaz:
https://doaj.org/article/7a8f8eecd84346d8b31558c256d8b1e5
Publikováno v:
Industrial Psychiatry Journal, Vol 33, Iss Suppl 1, Pp S97-S100 (2024)
Background: Chronic kidney disease (CKD) presents a profound clinical challenge, not only affecting physical health but also significantly impacting mental well-being. The complex interplay between CKD and psychiatric morbidities remains understudied
Externí odkaz:
https://doaj.org/article/35a8c2748ed5475e991d8a55734f55ae
Autor:
Aleš Oblak, Matic Kuclar, Katja Horvat Golob, Alina Holnthaner, Urška Battelino, Borut Škodlar, Jurij Bon
Publikováno v:
Frontiers in Psychology, Vol 15 (2024)
IntroductionPsychiatric comorbidities have proven a consistent challenge. Recent approaches emphasize the need to move away from categorical descriptions of symptom clusters towards a dimensional view of mental disorders. From the perspective of phen
Externí odkaz:
https://doaj.org/article/f8e00386585345ad9602a1f9ec085d7b
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-10 (2024)
Abstract Background Long-acting injectable depot buprenorphine may increase access to opioid agonist treatment (OAT) for patients with opioid use disorder in different treatment phases. The aim of this study was to explore the experiences of depot bu
Externí odkaz:
https://doaj.org/article/1c9415aa920c417ab0ad26d67a4ed480